Breaking AI & Tech News Analyzed

In a recent editorial, the Guardian highlighted the danger of Israel applying the same brutal tactics used in Gaza to Lebanon, and Medical Aid for Palestinians echoes that warning.Field reports from Lebanon describe a climate of terror fueled by mass forced‑displacement orders and relentless military strikes, including assaults on healthcare workers. Aid groups are scrambling to assist Palestinian refugees who have fled their homes, while many others remain trapped, deepening panic in already overcrowded camps plagued by poverty and scarce services.The Israeli military appears to be mirroring Gaza’s playbook: terrorising civilians, imposing forced displacement, and targeting humanitarian and medical infrastructure. Despite a declared cease‑fire in Gaza, Israeli attacks have killed more than 690 Palestinians since October, and restrictions on aid are creating lethal shortages of medicines and equipment.Meanwhile, the West Bank endures escalating settler violence and an Israeli annexation agenda that now threatens to extend into Lebanon, further destabilising the region.Medical Aid for Palestinians stresses that impunity for attacks on civilians and health services endangers both the populations they serve and the organisation’s staff across Gaza, the occupied West Bank and Lebanon.According to the statement, the UK government must not cherry‑pick when to uphold international law. It calls for decisive action to hold all perpetrators accountable, warning that inaction will lead to catastrophic human costs. The world, it asserts, cannot allow the horrors witnessed in Gaza to be replayed in Lebanon, and governments should not become complicit allies of such atrocities.

Israel has announced plans to occupy swathes of southern Lebanon, aiming to expand its buffer zone and prevent the return of approximately 600,000 residents. The move has raised concerns of long-term forced displacement and potential war crimes.Defence Minister Israel Katz stated that Israel will control the area up to the Litani River, about 19 miles from the Israel-Lebanon border, and destroy homes along the border. This approach has drawn criticism from Human Rights Watch, which warns that such actions could amount to forced displacement and wanton destruction, both considered war crimes.The conflict escalated after Hezbollah launched rockets at Israel on March 2, prompting an Israeli military campaign in Lebanon. The immediate goal is to push Hezbollah back from the border to prevent rocket fire into northern Israel. Israeli Prime Minister Benjamin Netanyahu has instructed the military to expand the buffer zone, though specifics remain unclear.The situation on the ground is dire, with over 1,268 people killed in Lebanon by Israeli actions, according to Lebanon's ministry of health. Additionally, 10 Israeli soldiers have been killed by Hezbollah, and two civilians in northern Israel have been killed by Hezbollah rocket fire. The conflict has also resulted in over 1 million displaced people, with many lacking official state shelters.The international community has condemned the violence, with the UN undersecretary-general for peace operations, Jean-Pierre Lacroix, calling the attacks on peacekeepers “unacceptable incidents” that must stop. The EU and the UN Security Council have also responded, with the latter holding an emergency session at France's request.

Palantir’s senior UK representative has warned ministers against yielding to ideologically motivated campaigners as they explore the possibility of terminating a £330 million NHS contract for the company’s Federated Data Platform (FDP).The FDP, an AI‑enabled system intended to unify patient information across the health service, is part of a broader portfolio that includes contracts with the Ministry of Defence, several police forces and the UK’s financial regulator.Louis Mosley, executive vice‑chair of Palantir UK, told The Times that abandoning the deal would jeopardise patient care and hinder progress on the NHS’s most pressing challenges. He highlighted that the platform is projected to generate £150 million in benefits by the end of the decade, delivering a £5 return for every pound spent.According to the Financial Times, senior officials have begun informal discussions about activating a break clause that would allow the FDP’s operation to be transferred to an alternative provider once the system becomes fully operational next year.Palantir, a US‑based data‑analytics firm with ties to the Israeli and US militaries and former U.S. Immigration and Customs Enforcement contracts, has faced sustained opposition from the British Medical Association, which has long criticised the use of its technology in patient‑care settings.Health officials acknowledge the reputational risk, noting that the controversy now extends beyond traditional Labour‑left and Green Party critics. A Department of Health and Social Care spokesperson emphasised that the FDP is designed to improve care coordination, accelerate cancer diagnoses and increase treatment capacity, while maintaining strict data‑security safeguards.Health Secretary Wes Streeting, speaking on the Guardian Politics Weekly podcast, recognised public unease about Palantir’s political affiliations, referencing founder Peter Thiel’s right‑wing connections. He reassured listeners that Palantir does not have direct access to patient data, stating, "The platform is operated by us; Palantir never sees the data."Adoption of Palantir’s technology within the NHS has risen from 118 to 151 organisations since June, though it remains short of the government’s target of 240 organisations by year‑end. Labour backbencher Clive Lewis noted that the issue is becoming a visible concern for voters, reflecting broader anxieties about AI and foreign‑owned infrastructure in critical public services.

The tragic case of Oliver Robinson, a 34-year-old who took his own life in November 2023, has sparked a campaign for stricter controls on private cannabis clinics in the UK. An inquest concluded that Robinson's prescription for medicinal cannabis, issued by Curaleaf Clinic, probably contributed to his death and acted as an obstacle to him receiving proper psychiatric and addiction care. Robinson had been struggling with depression and addiction, and had been treated at the Priory, a private mental health facility. He was initially prescribed medicinal cannabis in May 2022, which initially provided relief but ultimately worsened his condition. The coroner's report highlighted several failings in his care, including the use of an out-of-date GP summary care record and incomplete information in prescribing decisions. Alexander Robinson, Oliver's brother, is now advocating for tighter regulation of private cannabis clinics, including a ban on prescribing to patients with serious mental illness and greater oversight of the rapidly expanding industry. He believes that the current safeguards are not strong enough to protect vulnerable psychiatric patients. The UK government reported about 5,000 NHS prescriptions for licensed cannabis-based medicinal products in 2023, while freedom of information data showed that 659,293 unlicensed cannabis products were privately prescribed in 2024, more than double the number issued in 2023. Critics argue that there is limited evidence that cannabis is an effective treatment for depression and other common mental health conditions. Dr. Pavan Chahl, an expert psychiatrist, told Oliver's inquest that medicinal cannabis should not have been prescribed to someone with a history of severe psychiatric disorder, citing a lack of evidence for efficacy in depression and the risk of worsening symptoms. In response to the campaign, Curaleaf Clinic stated that it would engage constructively with any review or consultation aimed at strengthening patient safety across the sector.

The UK's National Health Service (NHS) is facing potential medicine shortages due to supply chain disruptions, with the head of NHS England, Jim Mackey, warning that some medicines could run out in weeks or even days. Mackey cited the country's reliance on imports, with 75% of medicines coming from abroad, as a major concern.Mackey revealed that a team is in place to focus on identifying potential risks in the supply chain, and that the NHS is working to mitigate the impact of any disruptions. He stated that the NHS generally has enough medicine to last a few weeks, but that some products may only have days' worth of supply.The concerns about medicine shortages come amid the ongoing conflict in the Middle East, which has raised worries about cost implications and supply disruption. Experts have noted that pharmacies are seeing disturbing spikes in prices, which can be an early indicator of challenges.The UK government has stated that there are currently no reported medicine shortages as a result of the conflict, but that they are monitoring the situation closely and have established processes in place to manage disruption across the health and social care sector.

Chinese dissident artist Gao Zhen, renowned for his satirical sculptures of Mao Zedong, has been tried in China on charges of 'defaming national heroes and martyrs'. His wife and a human rights group reported the trial.Gao, 69, was detained in 2024 during a visit to China from the US. He faces a maximum three-year prison sentence. The trial took place behind closed doors in Hebei province and ended without a verdict.Gao is known for his sculptures criticizing the 1966-1976 Cultural Revolution, a period of social turmoil and political persecution in China. His works include 'Miss Mao', featuring Mao with a Pinocchio nose and breasts, and 'Mao's Guilt', a bronze statue of Mao kneeling remorsefully.Gao's wife, Zhao Yaliang, and their seven-year-old son, a US citizen, are under exit bans and cannot leave China. Gao suffers from malnutrition and various health conditions, including lumbar spine disease and chronic knee and eye conditions.The trial highlights China's strict control over artistic expression and its efforts to suppress dissent. EU diplomats attempted to attend the trial but were blocked from entering the court.

The Drama, directed by Norwegian filmmaker Kristoffer Borgli, is a jeu d'esprit of outrage, a psychological meltdown that is more astutely articulated than in many another more solemnly intended film.The film centers around Charlie, played by Robert Pattinson, a young British art historian based in the US, and Emma, played by Zendaya, a beautiful and charming young woman who is deaf in one ear. Their whirlwind romance leads to a wedding, but their relationship is put to the test when Emma reveals a dark secret from her past: at 14, she planned a high school shooting but was thwarted when another shooting occurred at a local mall, killing a friend.The film's tone is a delicate balance of satire and thriller, leaving viewers questioning whether it's a black-comedic absurdity or a serious commentary on the darker aspects of human nature. The film's ingenuity lies in its generic ambiguity, making it difficult to categorize as solely a romantic comedy or a thriller.The Drama has sparked controversy and debate, with some critics praising its bold and insouciantly offensive approach, while others have expressed discomfort with its handling of sensitive topics like gun violence and mental health.Despite some critics arguing that the film slightly falls down in its portrayal of the aftermath of Emma's non-crime, it offers a thought-provoking exploration of the human psyche and the complexities of relationships.The Drama is set to release in Australia on April 2, and in the UK and US on April 3.

In Mexico, a mother's determination to navigate the country's beleaguered cancer care system has become a defining feature of her daily life. Faced with a healthcare system in crisis, she finds herself unceasingly vigilant in her quest for adequate treatment.The situation in Mexico's healthcare sector is marked by significant challenges, particularly in the realm of cancer care. Patients and families are often left to struggle with accessing timely and effective treatment, leading to a heavy emotional and financial toll.For this mother, the reality of her child's health battle is a harsh reminder of the system's shortcomings. Her story serves as a poignant example of the human cost of healthcare deficiencies and the resilience of those affected.

Digital violence is on the rise in Africa, driven by the rapid growth of internet access and high youth populations. Experts warn that this trend has severe consequences, including mental health problems, withdrawal from public and economic life, physical attacks, and femicide.In Africa, internet access is growing exponentially, with more than 70% of the population under 30. This has created a toxic online environment with dire real-life consequences. A study across five countries in sub-Saharan Africa found that 28% of women had experienced online violence. As internet access expands, this number is expected to rise.Primary targets include women in politics, human rights activists, journalists, and women with a public profile. 46% of female parliamentarians across 50 African countries have been the target of sexist attacks online, and 42% have received threats of death, rape, beating, or abduction, often through social media.Legislation and digital literacy are crucial in combating digital violence. Only 38% of people on the continent are internet users, and among women, the figure falls to 31%. Experts stress that platforms need to be accountable for the harm that is taking place on them and put user safety over profit.Examples of digital violence include doxing, deepfake abuse, sexual harassment, intimidation, and sextortion. These actions can lead to stalking, physical violence, and damage to reputation. Globally, nearly two in every five women will experience tech-facilitated violence, while 85% of women who are online have witnessed or encountered online abuse.Fewer than 40% of countries have laws protecting women from cyber harassment or cyber stalking, leaving 44% of the world’s women and girls – 1.8 billion – without access to legal protection. In Africa, about 17 countries have introduced legislation looking at cybercrime, but most do not acknowledge the gendered nature of abuse.